Conmed (CNMD) Long-Term Deferred Tax (2010 - 2025)

Conmed has reported Long-Term Deferred Tax for 16 years, with the latest figure at $13.3 million in Q4 2025.

• For the quarter ending Q4 2025, Long-Term Deferred Tax rose 20.24% year-over-year to $13.3 million; the trailing twelve-month figure through Dec 2025 stood at $13.3 million (up 20.24% YoY), and the FY2025 full-year result was $13.3 million, up 20.24% from the prior year.
• Long-Term Deferred Tax for Q4 2025 stood at $13.3 million, up from $11.1 million in the prior quarter.
• The five-year high for Long-Term Deferred Tax was $13.3 million in Q4 2025, with the low at $9.6 million in Q4 2022.
• Historically, Long-Term Deferred Tax has averaged $11.0 million across 5 years, with a median of $11.1 million in 2024.
• Annual changes were most pronounced in 2021 — Long-Term Deferred Tax surged 41.14% — and 2024, when it retreated 1.27%.
• Conmed's Long-Term Deferred Tax stood at $9.7 million in 2021, then fell by 0.07% to $9.6 million in 2022, then rose by 16.18% to $11.2 million in 2023, then declined by 1.27% to $11.1 million in 2024, then rose by 20.24% to $13.3 million in 2025.
• The last three Long-Term Deferred Tax figures came in at $13.3 million (Q4 2025), $11.1 million (Q4 2024), and $11.2 million (Q4 2023), per Business Quant data.